![](https://i0.wp.com/hcs-pharma.com/wp-content/uploads/2021/11/NHRI_award_ceremony_2021-11-10_180506.jpg?resize=413%2C585&ssl=1)
Key company (關鍵新創) in “Partnering and Medical Innovation” category (攜手同行暨創醫獎) from National Health Research Institute (NHRI) of Taiwan – 2021
![](https://i0.wp.com/hcs-pharma.com/wp-content/uploads/2020/04/4.png?resize=300%2C300&ssl=1)
The French Research Tax Credit (Crédit d’impôt recherche,CIR) is general and does not target any specific sector or type of company – unlike most direct aid to R&D and innovation. Working with us allows you to benefit of CIR for certain services.
![](https://i0.wp.com/hcs-pharma.com/wp-content/uploads/2020/04/3.png?resize=300%2C300&ssl=1)
The status of Young Innovative Company (JEI) recognize young companies very active in R&D. this distinction is given by the french ministry of research.